Tag: heart failure

Socioeconomic status and geographic region affect patient access to ICDs in...

There is a disparity between indications for and utilisation of implantable cardioverter defibrillators (ICDs) in Asian patients with heart failure, a recent study finds....

Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised...

  Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead or hospitalised within six months, reports a European Society of Cardiology (ESC) study...

Confirm Rx ICM: Convenient. Connected. Continuous.

This video has been sponsored by Abbott. The Confirm Rx implantable cardiac monitor (ICM) is the world’s first and only insertable cardiac monitor that combines...
Impulse Dynamics' Optimizer device

Cardiac contractility modulation device approved in China

The Optimizer system developed by Impulse Dynamics has received approval from the China Food and Drug Administration (CFDA). The Optimizer is an implantable cardiac...

US$50 million raised for SOLVE-CRT study on wireless CRT technology

EBR Systems has raised US$50 million to conduct the global SOLVE-CRT (stimulation of the left ventricle endocardially) study. SOLVE-CRT is a pivotal clinical trial intended to establish safety...

Catheter ablation lowers mortality in atrial fibrillation patients with heart failure

Catheter ablation of atrial fibrillation significantly reduces mortality and hospitalisation in atrial fibrillation patients with heart failure in comparison with conventional treatment, data from...

Abbott’s Full MagLev HeartMate 3 LVAD receives FDA approval

The FDA has approved the Full MagLev HeartMate 3 (Abbott) left ventricular assist device for use in heart failure patients in need of short-term...

EHRA Inventors Award ideas focus on cardiac remote monitoring and CRT...

For the second-year running, the European Heart Rhythm Association (EHRA) held the EHRA Inventors Award competition at EHRA-EUROPACE CARDIOSTIM (18‒21 June, Vienna, Austria), a...

CE mark granted to Medtronic for Attain Stability Quad MRI SureScan...

Medtronic has received CE mark for the Attain Stability Quad MRI SureScan left heart lead. The device offers active-fixation technology, designed for precise lead...

Heart failure patient and clinician risk perceptions differ drastically

Physicians identified a majority of patients with advanced heart failure as at high risk for transplant, left ventricular assist device (LVAD) or death while...

European Commission grants marketing authorisation to Vifor for patiromer hyperkalaemia treatment

The European Commission has granted marketing authorisation for sodium-free potassium binder, patiromer (Valtessa; Vifor Fresenius Medical Care Renal Pharma, Vifor UK), for the treatment...

Gaining a few pounds may increase long-term heart failure risk

Gaining even a little weight over time may alter the structure and function of heart muscle, affecting long-term risk of heart failure, according to...
Automated external defibrillator

Late-breaking trials identify early onset of heart failure and lack of...

For the first time this year, late-breaking clinical trials session were held at the Asian Pacific Society of Cardiology (APSC) Congress, to highlight world-class...

The Sound Doctor releases 40 heart failure films for patients

The Sound Doctor, a UK-based provider of health-related film and audio content for patients, has announced a series of 40 films on heart failure. The...

CRT optimisation: Why a sensor-based strategy may be the optimal solution

This video has been sponsored by LivaNova. Over the past two decades there have been several optimisation strategies, whether they are echo-guided or EKG-guided, aimed...

Unemployment associated with 50% higher risk of death in heart failure...

Unemployment is associated with a 50% higher risk of death in patients with heart failure, according to research presented at Heart Failure 2017 and...

Physical activity may ward off heart damage

Physical activity can lower the risk of heart damage in middle-aged and older adults and reduce the levels of heart damage in people who...

ACC 2017: More hospitalisations and deaths for US heart failure patients...

Patients with heart failure in the USA are more likely to be hospitalised and more likely to die during the colder winter months, according...

Increased physical activity, lower BMI may lower heart failure risk

While lifestyle patterns, including physical activity and body mass index (BMI), are associated with overall heart failure risk, they are more strongly associated with...

Cardiac resynchronisation therapy upgrade is less favourable than de novo implantations

Results from a large multicentre observational study have shown that patients undergoing cardiac resynchronisation therapy (CRT) upgrade had worse clinical response and long-term survival...

Flu, pneumonia vaccines may improve health of heart failure patients

Flu and pneumonia vaccines may improve the quality of life and outcomes of heart failure patients by providing cost-effective protection against life-threatening respiratory infections,...

Biotronik launches a new series of Ilivia CRT devices

Biotronik has announced the launch of a new series of cardiac resynchronisation therapy (CRT) devices with several functionalities that allow physicians to offer an...

Latest statistics show heart failure on the rise

The number of adults living with heart failure increased from about 5.7 million (2009-2012) to about 6.5 million (2011-2014), according to the American Heart...

Educational Supplement ‒ St. Jude Medical: Tackling heart failure with innovative...

This educational supplement is only available in countries outside the USA. This educational supplement contains highlights of the 5th edition of The Future of Heart...

AHA 2016: Transcatheter atrial shunt benefits persist through one year in...

Twelve-month results of the REDUCE LAP HF (Reduce elevated left atrial pressure in patients with heart failure) trial have shown both continued device patency...

Christian Butter wins best abstract for SELECT-LV final trial results at...

Christian Butter (Heart Center Brandenburg, Bernau bei Berlin, Germany) was awarded best abstract at the XVII International Symposium on Progress in Clinical Pacing (29...

Medtronic receives CE mark for less-invasive HVAD implant procedure

Medtronic’s HVAD system left ventricular assist device (LVAD) has received CE mark for a less-invasive implant procedure in patients with advanced heart failure. The...

CASE REPORT: WiSE CRT technology ‒ a feasible and effective alternative...

This case report has been written by Timothy Betts (consultant cardiologist and electrophysiologist, Oxford University Hospitals NHS Foundation Trust, Oxford, UK) and has been sponsored by...

Insights into current heart failure management

Piotr Ponikowski (Centre for Heart Disease, Clinical Military Hospital, Wroclaw, Poland), chairperson of the 2016 European Society of Cardiology (ESC) Guidelines for the diagnosis...

AHA 2016: HeartMate 3 LVAS improves clinical outcomes compared with HeartMate...

A prespecified primary analysis of the MOMENTUM 3 US IDE clinical study has indicated improvement in clinical outcomes for advanced heart failure patients implanted...

AHA 2016: Multisensor algorithm may help predict worsening heart failure

Results from the MultiSENSE study have demonstrated that a new multisensor algorithm, the HeartLogic Heart Failure Diagnostic Service (Boston Scientific), provides a timely alert...

AHA 2016: Elizabeth M McNally wins AHA prize for research into...

The American Heart Association (AHA) awarded its Basic Research Prize for 2016 to Elizabeth M McNally (Chicago, USA) for “Ground-breaking investigations of novel genetic...

AHA 2016: Combination of drug therapy and left ventricular assist device...

More than a third of advanced heart failure patients treated with a left ventricular assist device (LVAD) and intensive drug therapy have recovered their heart function enough...

Biotronik launches Inventra ICD for heart failure patients with higher defibrillation...

Biotronik has announced the US launch of Inventra HF-T, an implantable cardioverter defibrillator (ICD) that delivers “ultra-high” energy with 42 joules (J) on the...

Quadra Allure MP CRT-P gets CE mark approval for MRI labeling

St Jude Medical has announced CE mark approval for magnetic resonance (MR) conditional labeling for the company’s Quadra Allure MP cardiac resynchronisation therapy pacemaker (CRT-P). The...

Painkillers linked to increased risk of heart failure

Commonly used prescribed painkillers for treating pain and inflammation are associated with an increased risk of hospital admission for heart failure, finds a study...

ESC 2016: Remote monitoring for heart failure may not improve clinical...

Two randomised clinical trials presented at a Hot Line session of the European Society of Cardiology Congress (ESC; 27‒31 August, Rome, Italy) have shown...

EBR Systems receives FDA approval to begin IDE study of its...

EBR Systems has announced the US Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) for its WiSE (Wireless Stimulation Endocardially) technology for cardiac...

ESC 2016: Rethink of ICD implantation in non-ischaemic heart failure may...

Implantable cardioverter-defibrillators (ICDs) do not improve overall long-term survival compared to medical treatment in patients with non-ischaemic systolic heart failure, according to results of...

New alliance for heart failure calls for improved care for condition

A coalition of charities, patient groups, professional bodies and healthcare companies with an interest in heart failure has been established to raise the profile...

Cardiac resynchronisation therapy with SonR automated feature helps to reduce hospitalisation...

Results from the RESPOND-CRT trial have shown a 35% risk reduction in hospitalisation at two years for heart failure patients implanted with cardiac resynchronisation...

Insights into genetically-targeted prevention of atrial fibrillation in heart failure patients

The current need for new preventative therapies of atrial fibrillation in chronic heart failure patients—with fewer side effects than currently available treatment strategies—has led...

Many drugs can cause or worsen heart failure, American Heart Association...

Commonly used medications and nutritional supplements may cause or worsen heart failure, according to the first scientific statement from the American Heart Association to...

Wireless CRT has the potential to improve response in heart failure...

The world’s only wireless endocardial pacing system for cardiac resynchronisation therapy (CRT)—WiSE (Wireless Stimulation of the Endocardium) CRT System (EBR Systems)—is showing promise treating...